| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 3.78e-08 | 55 | 70 | 6 | GO:0042974 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 4.23e-07 | 82 | 70 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 1.01e-06 | 95 | 70 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.96e-05 | 187 | 70 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.36e-04 | 417 | 70 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 6.53e-04 | 11 | 70 | 2 | GO:0019870 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 6.61e-08 | 108 | 68 | 7 | GO:0035019 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 2.18e-07 | 78 | 68 | 6 | GO:0001825 | |
| GeneOntologyBiologicalProcess | oogenesis | 8.15e-07 | 156 | 68 | 7 | GO:0048477 | |
| GeneOntologyBiologicalProcess | oocyte development | 9.03e-07 | 99 | 68 | 6 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.14e-06 | 103 | 68 | 6 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | PRAMEF5 NF1 PRAMEF19 EIF3A PRAMEF4 PRAMEF18 WNK2 PRAMEF11 PRAMEF6 | 4.67e-06 | 385 | 68 | 9 | GO:0070372 |
| GeneOntologyBiologicalProcess | female gamete generation | 8.70e-06 | 223 | 68 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | PRAMEF5 NF1 PRAMEF19 EIF3A PRAMEF4 PRAMEF18 WNK2 PRAMEF11 PRAMEF6 | 9.06e-06 | 418 | 68 | 9 | GO:0070371 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.29e-05 | 237 | 68 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.48e-05 | 242 | 68 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | blastocyst development | 2.75e-05 | 179 | 68 | 6 | GO:0001824 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | GSDME PRAMEF5 NF1 PRAMEF19 EIF3A PRAMEF4 PRAMEF18 IL6R WNK2 PRAMEF11 PRAMEF6 | 6.71e-05 | 815 | 68 | 11 | GO:0043408 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | PRAMEF25 PRAMEF5 PRAMEF19 EVI2B CARD16 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 PCNT | 7.21e-05 | 1133 | 68 | 13 | GO:0043066 |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | PRAMEF25 PRAMEF5 PRAMEF19 EVI2B CARD16 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 PCNT | 1.01e-04 | 1171 | 68 | 13 | GO:0043069 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | IL12RB2 PRAMEF25 PRAMEF5 NF1 PRAMEF19 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 IL4 IL6R PRAMEF11 PRAMEF6 | 1.18e-04 | 1190 | 68 | 13 | GO:0008284 |
| GeneOntologyBiologicalProcess | negative regulation of chronic inflammatory response | 1.59e-04 | 6 | 68 | 2 | GO:0002677 | |
| GeneOntologyBiologicalProcess | germ cell development | REC114 PRAMEF5 PRAMEF19 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 1.81e-04 | 482 | 68 | 8 | GO:0007281 |
| GeneOntologyBiologicalProcess | MAPK cascade | GSDME PRAMEF5 NF1 PRAMEF19 EIF3A PRAMEF4 PRAMEF18 IL6R WNK2 PRAMEF11 PRAMEF6 | 2.14e-04 | 930 | 68 | 11 | GO:0000165 |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 2.23e-04 | 7 | 68 | 2 | GO:1903288 | |
| GeneOntologyBiologicalProcess | regulation of CD40 signaling pathway | 2.23e-04 | 7 | 68 | 2 | GO:2000348 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin production | 2.74e-04 | 95 | 68 | 4 | GO:0002637 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | REC114 PRAMEF5 PRAMEF19 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 3.31e-04 | 527 | 68 | 8 | GO:0022412 |
| GeneOntologyBiologicalProcess | gamete generation | BCAP31 REC114 PRAMEF5 PRAMEF19 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 3.42e-04 | 982 | 68 | 11 | GO:0007276 |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 3.59e-04 | 42 | 68 | 3 | GO:0002360 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 3.80e-04 | 9 | 68 | 2 | GO:1903286 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | PRAMEF25 PRAMEF5 NF1 PRAMEF19 PRAMEF4 PRAMEF18 ZHX2 IL4 PRAMEF11 PRAMEF6 | 5.59e-04 | 875 | 68 | 10 | GO:0045596 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | BCAP31 REC114 PRAMEF5 PRAMEF19 CCDC87 OCA2 PRKDC PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 6.47e-04 | 1235 | 68 | 12 | GO:0003006 |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | SELE CD1A GSDME NF1 CD22 ERMAP EVI2B PRKDC TNFAIP3 WNK1 IL4 IL6R | 6.81e-04 | 1242 | 68 | 12 | GO:0002684 |
| GeneOntologyBiologicalProcess | regulation of chronic inflammatory response | 6.92e-04 | 12 | 68 | 2 | GO:0002676 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion involved in gastrulation | 6.92e-04 | 12 | 68 | 2 | GO:0070587 | |
| GeneOntologyBiologicalProcess | negative regulation of heterotypic cell-cell adhesion | 6.92e-04 | 12 | 68 | 2 | GO:0034115 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | PRAMEF5 NF1 PRAMEF19 NUP133 PRKDC PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT | 7.32e-04 | 906 | 68 | 10 | GO:0043009 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.09e-08 | 47 | 70 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | motile cilium | PRAMEF5 PRAMEF19 PRAMEF4 PRAMEF18 TAS2R50 PRAMEF11 PRAMEF6 PCNT | 2.41e-05 | 355 | 70 | 8 | GO:0031514 |
| GeneOntologyCellularComponent | acrosomal vesicle | 6.61e-05 | 206 | 70 | 6 | GO:0001669 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 7.74e-05 | 212 | 70 | 6 | GO:0031461 | |
| GeneOntologyCellularComponent | side of membrane | SELE IL12RB2 CD1A BCAP31 CD22 NTM ERMAP IL4 IL6R OPCML EPM2AIP1 | 1.47e-04 | 875 | 70 | 11 | GO:0098552 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 1.16e-03 | 352 | 70 | 6 | GO:0000151 | |
| MousePheno | abnormal cecum morphology | PRAMEF5 PRAMEF19 SRPK3 CLMP PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 4.40e-09 | 99 | 55 | 8 | MP:0000494 |
| MousePheno | abnormal duodenum morphology | 5.14e-09 | 64 | 55 | 7 | MP:0003271 | |
| MousePheno | abnormal jejunum morphology | 1.13e-08 | 41 | 55 | 6 | MP:0004002 | |
| MousePheno | abnormal spermatogonia proliferation | 2.66e-08 | 47 | 55 | 6 | MP:0002685 | |
| MousePheno | abnormal large intestine morphology | PRAMEF5 PRAMEF19 SRPK3 CLMP PRKDC PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 1.15e-06 | 276 | 55 | 9 | MP:0000489 |
| MousePheno | increased kidney weight | 1.50e-06 | 145 | 55 | 7 | MP:0003917 | |
| MousePheno | abnormal testis size | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 1.55e-06 | 915 | 55 | 15 | MP:0004849 |
| MousePheno | abnormal circulating amylase level | 2.44e-06 | 156 | 55 | 7 | MP:0008804 | |
| MousePheno | enlarged urinary bladder | 5.97e-06 | 116 | 55 | 6 | MP:0011874 | |
| MousePheno | increased circulating amylase level | 6.92e-06 | 119 | 55 | 6 | MP:0008806 | |
| MousePheno | abnormal small intestine morphology | 8.08e-06 | 187 | 55 | 7 | MP:0000496 | |
| MousePheno | increased male germ cell apoptosis | 8.67e-06 | 189 | 55 | 7 | MP:0014052 | |
| MousePheno | abnormal testis morphology | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 1.20e-05 | 1081 | 55 | 15 | MP:0001146 |
| MousePheno | abnormal kidney weight | 1.62e-05 | 208 | 55 | 7 | MP:0002707 | |
| MousePheno | abnormal testis weight | REC114 PRAMEF5 TBC1D4 PRAMEF19 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 1.95e-05 | 391 | 55 | 9 | MP:0004850 |
| MousePheno | cataract | PRAMEF5 PRAMEF19 SREBF2 SLC37A2 OAT PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT | 2.04e-05 | 497 | 55 | 10 | MP:0001304 |
| MousePheno | abnormal male germ cell apoptosis | 3.64e-05 | 236 | 55 | 7 | MP:0008280 | |
| MousePheno | hearing/vestibular/ear phenotype | GSDME PRAMEF5 NF1 TRPA1 PRAMEF19 NISCH OCA2 PRAMEF4 PRAMEF18 PPIP5K2 ABHD12 PRAMEF11 PRAMEF6 | 3.66e-05 | 905 | 55 | 13 | MP:0005377 |
| MousePheno | abnormal vitreous body morphology | PRAMEF5 PRAMEF19 ALG11 SLC37A2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT | 4.03e-05 | 429 | 55 | 9 | MP:0002699 |
| MousePheno | abnormal male germ cell physiology | 4.50e-05 | 244 | 55 | 7 | MP:0020362 | |
| MousePheno | abnormal intestine morphology | PRAMEF5 PRAMEF19 SRPK3 CLMP PRKDC PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 | 4.56e-05 | 546 | 55 | 10 | MP:0000477 |
| MousePheno | abnormal sex determination | REC114 PRAMEF5 TMEM45A PRAMEF19 PEG3 OCA2 TNFAIP3 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 5.73e-05 | 945 | 55 | 13 | MP:0002210 |
| MousePheno | small testis | REC114 PRAMEF5 TMEM45A PRAMEF19 PEG3 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 6.71e-05 | 823 | 55 | 12 | MP:0001147 |
| MousePheno | enlarged kidney | PRAMEF5 PRAMEF19 EVI2B OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 6.73e-05 | 354 | 55 | 8 | MP:0003068 |
| MousePheno | abnormal auditory brainstem response | PRAMEF5 TRPA1 PRAMEF19 NISCH PRAMEF4 PRAMEF18 PPIP5K2 ABHD12 PRAMEF11 PRAMEF6 | 7.15e-05 | 576 | 55 | 10 | MP:0004738 |
| MousePheno | abnormal germ cell physiology | 7.95e-05 | 267 | 55 | 7 | MP:0020363 | |
| MousePheno | decreased testis weight | REC114 PRAMEF5 PRAMEF19 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 9.17e-05 | 370 | 55 | 8 | MP:0004852 |
| MousePheno | abnormal hearing electrophysiology | PRAMEF5 TRPA1 PRAMEF19 NISCH PRAMEF4 PRAMEF18 PPIP5K2 ABHD12 PRAMEF11 PRAMEF6 | 9.23e-05 | 594 | 55 | 10 | MP:0006335 |
| MousePheno | abnormal male reproductive gland morphology | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 9.48e-05 | 1290 | 55 | 15 | MP:0013325 |
| MousePheno | small gonad | REC114 PRAMEF5 TMEM45A PRAMEF19 PEG3 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 1.34e-04 | 885 | 55 | 12 | MP:0001116 |
| MousePheno | abnormal primary sex determination | REC114 PRAMEF5 TMEM45A PRAMEF19 PEG3 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 1.59e-04 | 901 | 55 | 12 | MP:0002211 |
| MousePheno | abnormal tail morphology | 1.65e-04 | 403 | 55 | 8 | MP:0002111 | |
| MousePheno | abnormal hearing physiology | PRAMEF5 TRPA1 PRAMEF19 NISCH PRAMEF4 PRAMEF18 PPIP5K2 ABHD12 PRAMEF11 PRAMEF6 | 1.77e-04 | 643 | 55 | 10 | MP:0001963 |
| MousePheno | abnormal internal male genitalia morphology | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 2.22e-04 | 1392 | 55 | 15 | MP:0009205 |
| MousePheno | abnormal germ cell morphology | REC114 PRAMEF5 NF1 PRAMEF19 PEG3 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 2.50e-04 | 946 | 55 | 12 | MP:0002208 |
| MousePheno | abnormal male genitalia morphology | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 2.66e-04 | 1415 | 55 | 15 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | REC114 PRAMEF5 TBC1D4 NF1 TMEM45A PRAMEF19 PEG3 SLC37A2 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT FANCA | 2.66e-04 | 1415 | 55 | 15 | MP:0001145 |
| MousePheno | abnormal foam cell morphology | REC114 PRAMEF5 NF1 PRAMEF19 PEG3 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 2.71e-04 | 954 | 55 | 12 | MP:0009840 |
| MousePheno | abnormal ear physiology | PRAMEF5 TRPA1 PRAMEF19 NISCH PRAMEF4 PRAMEF18 PPIP5K2 ABHD12 PRAMEF11 PRAMEF6 | 2.92e-04 | 684 | 55 | 10 | MP:0003878 |
| MousePheno | decreased germ cell number | REC114 PRAMEF5 PRAMEF19 PEG3 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 3.02e-04 | 687 | 55 | 10 | MP:0002209 |
| MousePheno | abnormal lens morphology | PRAMEF5 PRAMEF19 SREBF2 SLC37A2 OAT PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT | 3.47e-04 | 699 | 55 | 10 | MP:0001303 |
| MousePheno | azoospermia | 3.77e-04 | 244 | 55 | 6 | MP:0005159 | |
| MousePheno | abnormal urinary bladder morphology | 4.02e-04 | 247 | 55 | 6 | MP:0000538 | |
| MousePheno | abnormal stomach morphology | 4.11e-04 | 248 | 55 | 6 | MP:0000470 | |
| MousePheno | salivary gland inflammation | 4.41e-04 | 38 | 55 | 3 | MP:0001870 | |
| MousePheno | absent gametes | 4.86e-04 | 256 | 55 | 6 | MP:0001117 | |
| MousePheno | digestive/alimentary phenotype | IL12RB2 PRAMEF5 NF1 PRAMEF19 SRPK3 CLMP OCA2 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 PCNT | 5.01e-04 | 1500 | 55 | 15 | MP:0005381 |
| MousePheno | abnormal spermatogenesis | REC114 PRAMEF5 NF1 PRAMEF19 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 7.11e-04 | 910 | 55 | 11 | MP:0001156 |
| MousePheno | abnormal gametogenesis | REC114 PRAMEF5 NF1 PRAMEF19 PEG3 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 FANCA | 7.65e-04 | 1070 | 55 | 12 | MP:0001929 |
| MousePheno | enlarged lymph nodes | PRAMEF5 PRAMEF19 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 7.69e-04 | 507 | 55 | 8 | MP:0000702 |
| MousePheno | abnormal digestive system morphology | PRAMEF5 NF1 PRAMEF19 SRPK3 CLMP OCA2 PRKDC PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 PCNT | 7.94e-04 | 1233 | 55 | 13 | MP:0000462 |
| MousePheno | absent mature B cells | 8.17e-04 | 11 | 55 | 2 | MP:0008212 | |
| MousePheno | enlarged sperm head | 8.17e-04 | 11 | 55 | 2 | MP:0009233 | |
| MousePheno | abnormal lymph node morphology | PRAMEF5 PRAMEF19 SLC37A2 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 1.27e-03 | 683 | 55 | 9 | MP:0002339 |
| MousePheno | small kidney | 1.32e-03 | 425 | 55 | 7 | MP:0002989 | |
| MousePheno | abnormal lymph node size | PRAMEF5 PRAMEF19 PRKDC TNFAIP3 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 1.48e-03 | 561 | 55 | 8 | MP:0000701 |
| MousePheno | abnormal seminal vesicle morphology | 1.52e-03 | 319 | 55 | 6 | MP:0002059 | |
| MousePheno | abnormal salivary gland physiology | 1.53e-03 | 58 | 55 | 3 | MP:0005310 | |
| MousePheno | abnormal merocrine gland physiology | 1.68e-03 | 60 | 55 | 3 | MP:0013557 | |
| MousePheno | abnormal male germ cell morphology | REC114 PRAMEF5 NF1 PRAMEF19 CCDC87 OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 1.70e-03 | 859 | 55 | 10 | MP:0006362 |
| MousePheno | abnormal kidney size | PRAMEF5 PRAMEF19 EVI2B OCA2 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 PCNT | 1.73e-03 | 714 | 55 | 9 | MP:0002706 |
| MousePheno | enlarged spleen | PRAMEF5 TMEM45A PRAMEF19 OCA2 TNFAIP3 PRAMEF4 PRAMEF18 ADGRF1 PRAMEF11 PRAMEF6 | 1.75e-03 | 862 | 55 | 10 | MP:0000691 |
| Domain | PRAME_family | 5.81e-11 | 19 | 70 | 6 | IPR026271 | |
| Domain | - | 1.97e-04 | 321 | 70 | 7 | 3.80.10.10 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.06e-04 | 6 | 70 | 2 | IPR024678 | |
| Domain | OSR1_C | 2.06e-04 | 6 | 70 | 2 | PF12202 | |
| Domain | L_dom-like | 2.24e-04 | 328 | 70 | 7 | IPR032675 | |
| Domain | IG_LIKE | 4.87e-04 | 491 | 70 | 8 | PS50835 | |
| Domain | Ig-like_dom | 5.71e-04 | 503 | 70 | 8 | IPR007110 | |
| Domain | IL6Ra-bind | 7.45e-04 | 11 | 70 | 2 | PF09240 | |
| Domain | TypeI_recpt_CBD | 7.45e-04 | 11 | 70 | 2 | IPR015321 | |
| Domain | - | 7.97e-04 | 663 | 70 | 9 | 2.60.40.10 | |
| Domain | IG | 9.93e-04 | 421 | 70 | 7 | SM00409 | |
| Domain | Ig_sub | 9.93e-04 | 421 | 70 | 7 | IPR003599 | |
| Domain | Ig-like_fold | 1.24e-03 | 706 | 70 | 9 | IPR013783 | |
| Domain | IGc2 | 1.88e-03 | 235 | 70 | 5 | SM00408 | |
| Domain | Ig_sub2 | 1.88e-03 | 235 | 70 | 5 | IPR003598 | |
| Domain | V-set | 5.04e-03 | 184 | 70 | 4 | PF07686 | |
| Domain | Ig_I-set | 5.64e-03 | 190 | 70 | 4 | IPR013098 | |
| Domain | ig | 5.64e-03 | 190 | 70 | 4 | PF00047 | |
| Domain | Immunoglobulin | 5.64e-03 | 190 | 70 | 4 | IPR013151 | |
| Domain | I-set | 5.64e-03 | 190 | 70 | 4 | PF07679 | |
| Domain | Ig_V-set | 6.63e-03 | 199 | 70 | 4 | IPR013106 | |
| Pubmed | REC114 PRAMEF5 PRAMEF19 PEG3 PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 | 4.92e-14 | 46 | 71 | 8 | 17287250 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 7.09e-13 | 17 | 71 | 6 | 23565261 | |
| Pubmed | 7.09e-13 | 17 | 71 | 6 | 37781892 | ||
| Pubmed | 1.06e-12 | 18 | 71 | 6 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.06e-12 | 18 | 71 | 6 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 1.06e-12 | 18 | 71 | 6 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 1.06e-12 | 18 | 71 | 6 | 29731491 | |
| Pubmed | 1.06e-12 | 18 | 71 | 6 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.55e-12 | 19 | 71 | 6 | 28604677 | |
| Pubmed | 2.21e-12 | 20 | 71 | 6 | 26694250 | ||
| Pubmed | 2.21e-12 | 20 | 71 | 6 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 2.21e-12 | 20 | 71 | 6 | 21425410 | |
| Pubmed | 4.24e-12 | 22 | 71 | 6 | 31729367 | ||
| Pubmed | 5.73e-12 | 23 | 71 | 6 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.00e-11 | 25 | 71 | 6 | 12620990 | |
| Pubmed | 1.00e-11 | 25 | 71 | 6 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 1.30e-11 | 26 | 71 | 6 | 18500982 | |
| Pubmed | 2.12e-11 | 28 | 71 | 6 | 25089626 | ||
| Pubmed | 3.02e-11 | 58 | 71 | 7 | 31598710 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 3.33e-11 | 30 | 71 | 6 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 5.07e-11 | 32 | 71 | 6 | 37889087 | |
| Pubmed | 9.03e-11 | 35 | 71 | 6 | 19389355 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 8.63e-10 | 50 | 71 | 6 | 31806660 | |
| Pubmed | 2.41e-09 | 59 | 71 | 6 | 11279525 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF5 EP400 PRAMEF19 NISCH PRKDC PRAMEF4 PRAMEF18 ABCA8 PRAMEF11 PRAMEF6 | 2.21e-07 | 564 | 71 | 10 | 21565611 |
| Pubmed | PRRG1 PRAMEF5 PRAMEF19 PEG3 SREBF2 SLC35F2 TNFAIP3 PRAMEF4 PRAMEF18 WNK1 PRAMEF11 PRAMEF6 PCNT | 2.65e-07 | 1084 | 71 | 13 | 11544199 | |
| Pubmed | 1.84e-06 | 407 | 71 | 8 | 12693553 | ||
| Pubmed | Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects. | 4.11e-06 | 2 | 71 | 2 | 24616287 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22174447 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 7891157 | ||
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 4.11e-06 | 2 | 71 | 2 | 35849656 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 27345391 | ||
| Pubmed | Regulation of learning and memory by meningeal immunity: a key role for IL-4. | 4.11e-06 | 2 | 71 | 2 | 20439540 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12819783 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 9.55e-06 | 363 | 71 | 7 | 14691545 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 22751694 | ||
| Pubmed | CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. | 1.23e-05 | 3 | 71 | 2 | 9670976 | |
| Pubmed | Resistance to the African trypanosomes is IFN-gamma dependent. | 1.23e-05 | 3 | 71 | 2 | 9862708 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21347312 | ||
| Pubmed | Wnk kinases are positive regulators of canonical Wnt/β-catenin signalling. | 1.23e-05 | 3 | 71 | 2 | 23797875 | |
| Pubmed | CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. | 1.23e-05 | 3 | 71 | 2 | 15466391 | |
| Pubmed | A de novo Alu insertion results in neurofibromatosis type 1. | 1.23e-05 | 3 | 71 | 2 | 1719426 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 10878379 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 23922938 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2114220 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9564894 | ||
| Pubmed | Maternal microRNAs are essential for mouse zygotic development. | 2.07e-05 | 273 | 71 | 6 | 17369397 | |
| Pubmed | Multiplex inheritance of component phenotypes in a murine model of lupus. | 2.46e-05 | 4 | 71 | 2 | 9922399 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20937822 | ||
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 2.46e-05 | 4 | 71 | 2 | 11571656 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 11498583 | ||
| Pubmed | Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. | 2.46e-05 | 4 | 71 | 2 | 16644864 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 34384519 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 10878373 | ||
| Pubmed | WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1. | 2.46e-05 | 4 | 71 | 2 | 31816312 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 2.59e-05 | 424 | 71 | 7 | 21731673 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 17151125 | ||
| Pubmed | Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation. | 4.09e-05 | 5 | 71 | 2 | 19155490 | |
| Pubmed | Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. | 4.09e-05 | 5 | 71 | 2 | 18781131 | |
| Pubmed | Duplication and positive selection among hominin-specific PRAME genes. | 4.09e-05 | 5 | 71 | 2 | 16159394 | |
| Pubmed | Spatiotemporal expression of IgLON family members in the developing mouse nervous system. | 4.09e-05 | 5 | 71 | 2 | 34599206 | |
| Pubmed | Intestinal inflammation alters the antigen-specific immune response to a skin commensal. | 4.09e-05 | 5 | 71 | 2 | 35649365 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 21219110 | ||
| Pubmed | 5.47e-05 | 325 | 71 | 6 | 36168628 | ||
| Pubmed | 5.56e-05 | 326 | 71 | 6 | 17015433 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 27479084 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 36961815 | ||
| Pubmed | WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. | 6.13e-05 | 6 | 71 | 2 | 21733846 | |
| Pubmed | PRAMEF5 TRPA1 PRAMEF19 PRAMEF4 PRAMEF18 IL6R PRAMEF11 PRAMEF6 | 6.93e-05 | 674 | 71 | 8 | 37196079 | |
| Pubmed | 7.05e-05 | 497 | 71 | 7 | 23414517 | ||
| Pubmed | 7.84e-05 | 347 | 71 | 6 | 16033648 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 20525693 | ||
| Pubmed | IL-4-induced SOX9 confers lineage plasticity to aged adult lung stem cells. | 8.57e-05 | 7 | 71 | 2 | 39088319 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 20525402 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 25109740 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 23387299 | ||
| Pubmed | Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. | 1.14e-04 | 8 | 71 | 2 | 19262574 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 34793707 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 23838290 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 16239576 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 16138909 | ||
| Pubmed | Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. | 1.83e-04 | 10 | 71 | 2 | 11197687 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 39349721 | ||
| Pubmed | Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. | 2.23e-04 | 11 | 71 | 2 | 19169254 | |
| Pubmed | Interleukin gene expression in mouse preimplantation development. | 2.23e-04 | 11 | 71 | 2 | 8770556 | |
| Pubmed | Common genetic variants in candidate genes and risk of familial lymphoid malignancies. | 2.27e-04 | 145 | 71 | 4 | 19573080 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | SELE PRAMEF25 PRAMEF5 PRAMEF19 ERMAP PRAMEF4 IL6R PRAMEF11 PRAMEF6 | 2.45e-04 | 1031 | 71 | 9 | 16710414 |
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 17908769 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 22980983 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 17035062 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 22724066 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 20145925 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 19495883 | ||
| Pubmed | 3.46e-04 | 162 | 71 | 4 | 25826454 | ||
| Pubmed | 3.68e-04 | 14 | 71 | 2 | 17152005 | ||
| Pubmed | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. | 4.24e-04 | 15 | 71 | 2 | 9804427 | |
| Pubmed | 4.24e-04 | 15 | 71 | 2 | 23548203 | ||
| Pubmed | 4.24e-04 | 15 | 71 | 2 | 19436707 | ||
| Pubmed | 4.80e-04 | 486 | 71 | 6 | 20936779 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 5.29e-04 | 910 | 71 | 8 | 36736316 | |
| Interaction | IGHM interactions | 4.25e-06 | 130 | 66 | 6 | int:IGHM | |
| Cytoband | 1p36.21 | 8.06e-12 | 63 | 71 | 7 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 8.96e-05 | 681 | 71 | 7 | chr1p36 | |
| Cytoband | 10q26 | 5.84e-04 | 23 | 71 | 2 | 10q26 | |
| Cytoband | 11q25 | 7.48e-04 | 26 | 71 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 1.07e-03 | 31 | 71 | 2 | chr11q25 | |
| GeneFamily | PRAME family | 3.09e-13 | 24 | 51 | 7 | 686 | |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 7.76e-05 | 5 | 51 | 2 | 1052 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 4.03e-10 | 34 | 71 | 6 | MM955 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.04e-08 | 57 | 71 | 6 | MM1262 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 8.80e-08 | 81 | 71 | 6 | MM938 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 2.23e-07 | 156 | 71 | 7 | MM550 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.75e-07 | 98 | 71 | 6 | MM592 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 2.75e-07 | 98 | 71 | 6 | MM3656 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 2.75e-07 | 98 | 71 | 6 | MM942 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | IL12RB2 PRAMEF5 PRAMEF19 PRAMEF4 PRAMEF18 PTGIR PRAMEF11 PRAMEF6 | 5.37e-07 | 261 | 71 | 8 | MM1277 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 5.88e-07 | 180 | 71 | 7 | MM612 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 2.06e-05 | 309 | 71 | 7 | MM1244 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | 2.79e-05 | 324 | 71 | 7 | M2700 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | GSDME PRAMEF5 PRAMEF19 PRAMEF4 PRAMEF18 IL4 PRAMEF11 PRAMEF6 | 3.58e-05 | 463 | 71 | 8 | MM1011 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 3.99e-05 | 232 | 71 | 6 | MM1019 | |
| Coexpression | RODWELL_AGING_KIDNEY_DN | 5.17e-05 | 148 | 71 | 5 | M5408 | |
| Coexpression | SANSOM_APC_TARGETS | 5.41e-05 | 245 | 71 | 6 | MM735 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | PRAMEF5 TRPA1 TMEM45A PRAMEF19 PRAMEF4 FITM1 PRAMEF18 ABCA8 PRAMEF11 PRAMEF6 | 6.12e-05 | 807 | 71 | 10 | MM855 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | PRAMEF5 PRAMEF19 ERMAP PRAMEF4 PRAMEF18 PRAMEF11 PRAMEF6 EPM2AIP1 | 1.09e-04 | 543 | 71 | 8 | MM997 |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 1.25e-04 | 94 | 71 | 4 | M18108 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 2.03e-04 | 198 | 71 | 5 | M4462 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 2.08e-04 | 199 | 71 | 5 | M5255 | |
| Coexpression | GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP | 2.08e-04 | 199 | 71 | 5 | M7800 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 2.21e-04 | 317 | 71 | 6 | MM956 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-07 | 180 | 71 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-07 | 190 | 71 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-07 | 194 | 71 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Severe-Treg|Severe / Disease group and Cell class | 6.75e-07 | 194 | 71 | 6 | 7d232d87262ec5f505901345da5113cabf821321 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 180 | 71 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 181 | 71 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 71 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 189 | 71 | 5 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 189 | 71 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 189 | 71 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 189 | 71 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 1.36e-05 | 191 | 71 | 5 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 192 | 71 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 192 | 71 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 192 | 71 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 192 | 71 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 192 | 71 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 193 | 71 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 193 | 71 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 194 | 71 | 5 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 194 | 71 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.49e-05 | 93 | 71 | 4 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 1.50e-05 | 195 | 71 | 5 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 196 | 71 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.54e-05 | 196 | 71 | 5 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 196 | 71 | 5 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-05 | 196 | 71 | 5 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 196 | 71 | 5 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.54e-05 | 196 | 71 | 5 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 196 | 71 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | (5)_Fibroblast-I|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.58e-05 | 197 | 71 | 5 | eb486995ad72a0fbb6410c54e8dcf4ee780c0986 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-05 | 197 | 71 | 5 | 54fb7197db3c0dc87a1114e1ab1d2bfafd564b35 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-05 | 198 | 71 | 5 | 03423d6c614440b9c738f75ac3f5a6941719a279 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 198 | 71 | 5 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.61e-05 | 198 | 71 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.65e-05 | 199 | 71 | 5 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-05 | 199 | 71 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 199 | 71 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.65e-05 | 199 | 71 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 200 | 71 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-05 | 200 | 71 | 5 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-05 | 200 | 71 | 5 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-05 | 200 | 71 | 5 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.08e-05 | 133 | 71 | 4 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-05 | 149 | 71 | 4 | a464c0fd54e3c9e1d40d95b49489cb9371dd7c24 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.95e-05 | 151 | 71 | 4 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 154 | 71 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 154 | 71 | 4 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 154 | 71 | 4 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 154 | 71 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 166 | 71 | 4 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 171 | 71 | 4 | d322cc042a6f4b4aa8ef80ae977edbce9e266d48 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 172 | 71 | 4 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 1.64e-04 | 172 | 71 | 4 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 172 | 71 | 4 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 172 | 71 | 4 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 172 | 71 | 4 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 172 | 71 | 4 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 173 | 71 | 4 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-04 | 173 | 71 | 4 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-04 | 173 | 71 | 4 | 120dd20e8a71f9169a1596b6171df7aa0b96dd15 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-04 | 173 | 71 | 4 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-04 | 173 | 71 | 4 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 173 | 71 | 4 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 173 | 71 | 4 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-04 | 173 | 71 | 4 | b2c55084ef6dac0e329c2e65c24cfe0045859c30 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-04 | 174 | 71 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 175 | 71 | 4 | 393da565f61ba640410419a0cabaaf5c1056580a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 175 | 71 | 4 | 271b56d4ab940959d28ca4b86ce2750350dfc717 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 175 | 71 | 4 | a72c6ceca5ddbd34f652e7302defefa2d105e17e | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.75e-04 | 175 | 71 | 4 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 175 | 71 | 4 | 9a462e9e6f7bbb64abb09ad6c080df3576073540 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 175 | 71 | 4 | 5168340c6045bbc7d67276afb719b051d1cb65a2 | |
| ToppCell | droplet-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 71 | 4 | 9739b0653c511ab017507a0c7ee4f6d7082e87db | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 177 | 71 | 4 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.83e-04 | 177 | 71 | 4 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 177 | 71 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 177 | 71 | 4 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-04 | 177 | 71 | 4 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 177 | 71 | 4 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 177 | 71 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 177 | 71 | 4 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-04 | 177 | 71 | 4 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 177 | 71 | 4 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Treg|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-04 | 178 | 71 | 4 | e37142a84d9713ff1571ce9f976842bf5c17c86f | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 178 | 71 | 4 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 178 | 71 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 179 | 71 | 4 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 180 | 71 | 4 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 180 | 71 | 4 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 1.95e-04 | 180 | 71 | 4 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 71 | 71 | 3 | 2220e1b02baa71961cfc85536bafeb313e588bf3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 71 | 71 | 3 | cc5de8bbcfefa2bf93cc137c74b49a745d5da229 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.99e-04 | 181 | 71 | 4 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 2.04e-04 | 182 | 71 | 4 | cd6e3a9f4eb4fe73b28da61d1d35c64fd9ffa892 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| Drug | 12 B | 1.58e-06 | 65 | 69 | 5 | CID000067222 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 6.69e-05 | 6 | 63 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | skin melanoma (is_implicated_in) | 4.02e-04 | 14 | 63 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 4.39e-04 | 1074 | 63 | 9 | C0006142 | |
| Disease | age at menopause | 4.70e-04 | 302 | 63 | 5 | EFO_0004704 | |
| Disease | Moyamoya Disease | 5.98e-04 | 17 | 63 | 2 | C0026654 | |
| Disease | Asthma | 6.78e-04 | 80 | 63 | 3 | C0004096 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 6.83e-04 | 328 | 63 | 5 | EFO_0008377, EFO_0008378 | |
| Disease | skin sensitivity to sun | 7.49e-04 | 19 | 63 | 2 | EFO_0004795 | |
| Disease | sunburn | 1.15e-03 | 96 | 63 | 3 | EFO_0003958 | |
| Disease | hearing impairment | 1.22e-03 | 98 | 63 | 3 | C1384666 | |
| Disease | cardiac troponin T measurement | 1.25e-03 | 219 | 63 | 4 | EFO_0005043 | |
| Disease | malaria | 1.37e-03 | 102 | 63 | 3 | EFO_0001068 | |
| Disease | suntan | 1.41e-03 | 103 | 63 | 3 | EFO_0004279 | |
| Disease | unipolar depression, irritable bowel syndrome | 1.64e-03 | 28 | 63 | 2 | EFO_0000555, EFO_0003761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VIVLWGIRLLLQRKK | 36 | Q2TAA5 | |
| VVRSCNILKWELELK | 1146 | Q96L91 | |
| ILCLIIEALFWKQIK | 601 | Q5T601 | |
| LQLLSLVTKKKRFWC | 31 | O60443 | |
| QREKCLRKRIWEKIA | 181 | Q008S8 | |
| HLLKIKNTFCLWKRL | 806 | Q8N2N9 | |
| LRLIKVILDELKCSW | 81 | Q9NVE4 | |
| SKDWLKIVRRVDCLL | 91 | Q7Z4M0 | |
| LRLSKLRRCVQWLKV | 166 | Q04671 | |
| KGVWLRLRKILFCVL | 66 | Q8N2K0 | |
| CLVCKEKLIIWKIAL | 116 | Q8WUM0 | |
| WKCLVVVSLRLLFLV | 11 | Q9P121 | |
| SWLDIIRRCLKKAIE | 361 | Q9C0I1 | |
| GWLINICRRKKELKA | 101 | O43861 | |
| ICRRKKELKARTVWL | 106 | O43861 | |
| ITWLLIKAKIDACKR | 16 | Q99665 | |
| RWQKIFKSRLVELLV | 31 | P51572 | |
| LLLLIGLALWFRKRC | 311 | P06126 | |
| CIWLDKVDLRKRIVN | 5116 | Q9Y6V0 | |
| LVAIIIIVLWKCLRK | 216 | P34910 | |
| DCLLAQKVRPRRWKL | 86 | Q5VWM3 | |
| LAPFLLWLRKCLRKA | 571 | P16581 | |
| ILRLRFLVKKWQEVD | 3206 | O95613 | |
| WRIKKFREACIELLP | 326 | Q9Y5Y3 | |
| RKTLIKLRNLCLDWL | 61 | Q9GZU2 | |
| WKCLVVVSLRLLFLV | 11 | Q14982 | |
| LLCRLVYKEILAWKV | 476 | Q8TED4 | |
| KQLIRFLKRLDRNLW | 101 | P05112 | |
| CIAIVLRFKKTWKLR | 381 | P08887 | |
| LKLCERVTKVLNWVR | 401 | Q14152 | |
| RLRKRIQGCWRQLLK | 1316 | Q5THR3 | |
| RIQALLGCLLKVLLW | 16 | A5D6W6 | |
| RCLNNWLRRGKTLKL | 336 | Q7L775 | |
| ILILWKFALLRKRIL | 246 | A4D1U4 | |
| ILECLEKRKISWLAL | 1291 | O15360 | |
| VLLWKNFILKRRRCI | 11 | A6NIL9 | |
| LLIKWCVLETIRLKA | 326 | Q9NYL5 | |
| RIKLCFLEDAQRIWK | 111 | Q5EG05 | |
| LAICGLKLQRRWKRT | 701 | P20273 | |
| VCLCLIWKQRRAKEK | 171 | Q96PL5 | |
| WRTKKLKHTFLLILC | 281 | P59544 | |
| LWELRKKFRCAVLKN | 751 | Q5K651 | |
| DCLLAQKVRPRRWKL | 86 | Q5SWL8 | |
| LTCLLLWVKQRKDLL | 166 | A6NGN4 | |
| HRKCLIKWLEVRKVC | 101 | Q9Y225 | |
| LLRRIKGKLFTWNIL | 26 | Q8IXU6 | |
| WKVCLRLRDNGLLAK | 391 | P04181 | |
| WRKRCLYLFVLLLLI | 31 | Q13326 | |
| GLLQLWKRKRCVLTE | 21 | Q9Y5J5 | |
| WKRKRCVLTERGLQL | 26 | Q9Y5J5 | |
| CWDIQRKRFVALKVV | 96 | Q9UPE1 | |
| WNLLKERKTDRVILF | 656 | O94911 | |
| LLIFLLVWLLIRRKD | 246 | Q9H6B4 | |
| LTCLLLWVKQRKDLL | 166 | O60810 | |
| CLLLWVKQRKDLLHL | 166 | Q5VXH4 | |
| VLTIIRSKRWDECLK | 596 | O75762 | |
| KKLNWCREVRKLVAL | 81 | P21580 | |
| RKAVFQRLKLWVCCL | 296 | P43119 | |
| LRLVRWLLKKVFQCR | 631 | Q12772 | |
| LLEHIRILKVLWCFL | 701 | Q9Y2I1 | |
| CLLLWVKQRKDLLHL | 166 | Q5TYX0 | |
| IIKRIFNILKFTWVL | 1641 | Q9H5I5 | |
| ILKWLREILICRNKF | 596 | P21359 | |
| LTCLLLWVKQRRDLL | 166 | O60813 | |
| ITWDKKLLNCRAKIR | 891 | O60343 | |
| RCIREFLKWSIKQIT | 1031 | P78527 | |
| LVIFLIWRCFLRNKT | 96 | O14668 | |
| EIVRWFKENRCLLKT | 671 | Q9Y6X8 | |
| LNAREKLIAWKVCLA | 286 | O43314 | |
| IKVLRSWCRQILKGL | 321 | Q9H4A3 | |
| KVLRSWCRQILKGLL | 296 | Q9Y3S1 | |
| FWFVLKVVLIIIRLK | 31 | Q9Y2P4 | |
| RLQDVKAQKVWCRFL | 41 | Q86YW5 | |
| AFITWLVKSRLKRLC | 241 | Q9NWC5 |